6635-13-8

Basic information

• Product Name: a-AMino-a-Methyl-cyclohexaneacetic acid
• Synonyms: a-AMino-a-Methyl-cyclohexaneacetic acid;2-Amino-2-cyclohexylpropanoic acid
• CAS NO: 6635-13-8
• Molecular Formula: C₉H₁₇NO₂
• Molecular Weight: 171.23678
• Mol File: 6635-13-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 297.8°Cat760mmHg
• Flash Point: 133.9°C
• Appearance: /
• Density: 1.108g/cm³
• Vapor Pressure: 0.000316mmHg at 25°C
• Refractive Index: 1.511
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: a-AMino-a-Methyl-cyclohexaneacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: a-AMino-a-Methyl-cyclohexaneacetic acid(6635-13-8)
• EPA Substance Registry System: a-AMino-a-Methyl-cyclohexaneacetic acid(6635-13-8)

Safety Data

• Hazardous Substances Data: 6635-13-8(Hazardous Substances Data)

Usage

General Description

a-AMino-a-Methyl-cyclohexaneacetic acid, also known as taurine, is an organic compound that is classified as an amino acid. It is a derivative of cysteine and is typically found in high concentrations in the brain, heart, and muscles. Taurine plays a vital role in several physiological processes, including bile salt formation, antioxidant activity, modulation of calcium signaling, and neurological functions. Additionally, it is often included in energy drinks and sports supplements due to its potential benefits for improving exercise performance and reducing muscle damage and fatigue. Taurine is also commonly added to pet food and infant formula due to its essential role in development and overall health.

InChI:InChI=1/C9H17NO2/c1-9(10,8(11)12)7-5-3-2-4-6-7/h7H,2-6,10H2,1H3,(H,11,12)

Upstream product

• 6326-77-8 5-cyclohexyl-5-methylhydantoin 

Relevant articles and documents

N-SUBSTITUTED HETEROCYCLIC DERIVATIVES USEFUL IN THE TREATMENT OF CARDIOVASCULAR DISORDERS

The present invention relates to N-substituted heterocyclic derivatives of formula: STR1 processes for their preparation, and pharmaceutical compositions which contain them. The compounds according to the invention are non-peptide compounds which oppose the action of angiotensin II. The compounds according to the invention are thus useful in the treatment of cardiovascular disorders such as hypertension and heart failure.

Dinitrogen heterocyclic derivatives N-substituted by a biphenylmethyl group, and the pharmaceutical compositions in which they are present

This invention relates to compounds of formula STR1 in which: R1 and R2 are similar or different and are each independently hydrogen or a group selected from CO2 N=C(NH2)2, CONHNHCONH2, CONHNHCSNH2, C(OC2 H5)=NCO2 CH3, COCH2 CO2 H5, N(OH)-CONHCOOC2 NCO2 CH3, COCH2 CO2 H5, N(OH)-CONHCOOC2 H5, C(OC2 H5)=NH or a nitrogen heterocycle; with the proviso that at least one of the substituents R1 or R2 is other than hydrogen; R3 is a hydrogen, a C1 -C6 alkyl, a C2 -C6 alkenyl, a C3 -C7 cycloalkyl, a phenyl, a phenylalkyl, or a phenylalkenyl; R4 and R5 are each independently a C1 -C6 alkyl, a C3 -C7 cycloalkyl, a phenyl or a phenylalkyl; or R4 and R5, bonded together, are either a group of the formula (CH2)n or a group of the formula (CH2)p Y (CH2)q, in which Y is either an oxygen atom, or a sulfur atom, or a substituted carbon atom, or a group N-R6, in which R6 is a hydrogen, a C1 -C4 alkyl, a phenylalkyl, a C1 -C4 alkylcarbonyl, a C1 -C4 halogenoalkylcarbonyl, a C1 -C4 polyhalogenoalkylcarbonyl, a benzolyl, an α-aminoacyl or a N-protecting group, or R4 and R5, together with the carbon atom to which they are bonded, form an indane or an adamantine; p+q=m; n is an integer between 2 and 11; m is an integer between 2 and 5; X is an oxygen or a sulfur atom; and z and t are zero or z+t=1; and its salts.